title: Cost-effectiveness of hysterectomy for benign gynecological conditions: a systematic review.
abstract: The objective of this study was to assess the cost-effectiveness of hysterectomy performed for benign indications. Hysterectomy remains the most common major gynecological operation in the Western world. Rates of hysterectomy have not declined as expected with the introduction of new treatment options. Furthermore, use of laparoscopic techniques varies widely within the Nordic countries. We designed a systematic review in a University Central Hospital. The sample included all published studies regarding the cost-effectiveness of hysterectomy performed for benign indications (n = 1666). Medline, Cochrane Library, PsycINFO, CINAHL, and Nursing databases were searched. Inclusion criteria were the availability of pre- and post-intervention health-related quality of life measures (HRQoL) and data on costs. HRQoL, costs, and cost-effectiveness of treatment were the main outcome measures. Studies (n = 24) focused on treatment of symptomatic fibroids (n = 8), treatment of heavy menstrual bleeding (n = 10), various surgical techniques (n = 5) and the effect of various indications for hysterectomy (n = 2). Follow-up periods varied from 4 months to over 10 years. SF/RAND-36 or EQ-5D measures and societal cost perspective were most commonly used. Only 11 studies used individual patient data. HRQoL following hysterectomy was generally good but costs were high. The cost-effectiveness depended on indication, age, and duration of follow-up. The cost-effectiveness of hysterectomy has been surprisingly poorly studied. Conclusions are difficult to draw due to different study designs, indications, follow-up times, and HRQoL instruments used. Rates of hysterectomy have declined less than expected with the introduction of new treatment modalities. Costs of surgery are high. Laparoscopic hysterectomy seems to be the least cost-effective, although further data from original patient cohorts with long-term follow-up are needed.
authors.affiliation: University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Lohja Hospital, Lohja, Finland.
authors.forename: Kristiina
authors.initials: K
authors.lastname: Pynnä
authors.forename: Piia
authors.initials: P
authors.lastname: Vuorela
authors.forename: Leena
authors.initials: L
authors.lastname: Lodenius
authors.forename: Jorma
authors.initials: J
authors.lastname: Paavonen
authors.forename: Risto P
authors.initials: RP
authors.lastname: Roine
authors.forename: Pirjo
authors.initials: P
authors.lastname: Räsänen
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000191:economics* / Q000379:methods / Q000706:statistics & numerical data; D007889:Leiomyoma / Q000191:economics / Q000601:surgery*; D008595:Menorrhagia / Q000191:economics / Q000601:surgery*; D008875:Middle Aged; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D014594:Uterine Neoplasms / Q000191:economics / Q000601:surgery*
keywords: Hysterectomy; benign; cost-effectiveness; costs; quality of life